Biopsys Medical

Biopsys Medical was a prominent medical technology company that specialized in the development and commercialization of minimally invasive breast biopsy systems. The company's flagship product, the Mammotome Breast Biopsy System, introduced vacuum-assisted biopsy technology, which significantly improved the accuracy and efficiency of breast tissue sampling. Founded in 1991 and headquartered in Irvine, California, Biopsys played a critical role in shifting breast cancer diagnosis from open surgical procedures to less invasive outpatient techniques. The company completed an initial public offering in 1996 before being acquired by Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, in 1997. Today, the Mammotome brand continues to be a market leader in the breast care space under the ownership of Danaher Corporation.